Sue Siegel has resigned her post as president emeritus of Affymetrix, the company said in a Securities and Exchange Commission filing last week.
 
Siegel, who was named president emeritus last April after resigning as president, will receive a severance package of $675,000 minus what she earned from her base salary of $426,000 since April 2006, Affy said.
 
She will also receive an accelerated vesting of stock options as if she had remained at her job through October 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.